The HPV testing and Pap test market was valued at $3.7 billion in 2021 and is expected to grow to $6.7 billion by 2031 with a CAGR of 6.1% from 2022 to 2031.HPV is a common sexually transmitted infection caused by the human papillomavirus. It can cause epithelial proliferation on cutaneous and mucosal surfaces. There are two categories of HPV, low-risk and high-risk, with high-risk types known to cause cervical and vaginal cancer. The most oncogenic type of HPV is HPV 16, accounting for nearly half of all cervical cancers, with HPV 16 and 18 accounting for 70% of cervical cancers.
Download the Complete Research Study Here in PDF Format @https://www.alliedmarketresearch.com/request-sample/14742
Key Market Players
Arbor vita corporation, Becton, Dickinson and Company, Femasys Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd, Seegene Inc, Hologic Inc., F. Hoffmann-La Roche AG, Qaigen NV
Product approval in the market
In July 2020, BD (Becton, Dickinson and Company), announced that it received approval for a pre-market approval (PMA) supplement from the U.S. Food and Drug Administration (FDA) for an expanded version of its BD Onclarity HPV Assay.
Product Launches in the market
In June 2022, Roche today announced the launch of a human papillomavirus (HPV) self-sampling solution in countries accepting the CE mark.
Cervical cancer screening is a vital part of women’s health and includes tests such as Pap tests, HPV testing, and co-testing. These tests check for high-risk HPV types, cervical cell changes, and both respectively. Women aged 21-29 are recommended their first Pap test at age 21 and subsequent tests every 3 years. Women aged 30-65 are recommended HPV tests or co-tests every 5 years or Pap tests every 3 years.
Download the Complete Research Study Here in PDF Format @https://www.alliedmarketresearch.com/checkout-final/115ef5495a8240ae4afa3e44a104be0c
Table of Contents for HPV Testing & Pap Test Market :
- Introduction
- Definition of HPV testing and Pap test
- Importance of HPV testing and Pap test
- HPV Testing Market
- Market size and growth rate
- Market segmentation (by end-user, by geography, etc.)
- Key players and competitive landscape
- Pap Test Market
- Market size and growth rate
- Market segmentation (by end-user, by geography, etc.)
- Key players and competitive landscape
- Comparison between HPV Testing and Pap Test
- Advantages and disadvantages of each test
- When to use HPV testing vs. Pap test
- Factors Driving the Market Growth
- Increasing awareness about cervical cancer
- Advances in testing technology
- Government initiatives to promote screening tests
- Challenges Facing the Market
- Limited access to screening tests in certain regions
- High cost of tests
- Lack of awareness and stigma associated with HPV and cervical cancer
- Future of the Market
- Projected market growth
- Emerging trends and technologies
- Potential impact of COVID-19 on the market
- Conclusion
- Summary of key findings
- Recommendations for stakeholders.